RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Haysaw, That would be my guess - that the conf call is primarily to coincide with the filing of the IND with Psychiatric, and also to fill us in on what Neurology had to say after completing their evaluation of the tox data. The conf call should help clear up some of the remaining uncertainties out there over dosing levels/durations, Neurology's overall stance on the histo/artifact issue, etc. Then we'll have approx 30 days to wait for Psychiatric's decision on the ADHD IND.

Fwiw, I did lighten up today, continuing my ongoing tradition of timing (and mistiming) this stock. The warrant share overhang factor is something I just don't have a good handle on, so I figure I'll let it settle out and then reevaluate the situation / stay flexible, etc. I still think we're likely to get good news from Neurology or they wouldn't have liberalized the dose at all. There are always question marks out there until we get the final verdict from Psychiatric, but the conf call should help clarify where we stand.